D'Souza, Richard

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Azizi, M., Schmieder, R. E., Mahfoud, F., Weber, M. A., Daemen, J., Davies, J., Basile, J., Kirtane, A. J., Wang, Y., Lobo, M. D., et al. (2018) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 740

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Böhm, M., Kario, K., Kandzari, D. E., Mahfoud, F., Weber, M. A., Schmieder, R. E., Tsioufis, K., Pocock, S., Konstantinidis, D., Choi, J. W., et al. (2020) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 606

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Azizi, M., Sanghvi, K., Saxena, M., Gosse, P., Reilly, J. P., Levy, T., Rump, L. C., Persu, A., Basile, J., Bloch, M. J., et al. (2021) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 439

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology

Hormonal Regulation and HypertensionBlood Pressure and Hypertension Studies

Cited by 347

Renal nitrate clearance in chronic kidney disease

Williams, J. K., Smallwood, M. J., Benjamin, N., D'Souza, R. J., Shore, A. C., Winyard, P. G., & Gilchrist, M. (2020) · Nitric Oxide

Nitric Oxide and Endothelin EffectsChronic Kidney Disease and Diabetes

Cited by 19